Article
Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time.
JCI insight - 8 Jul 2025
Wittenzellner Katja, Lengl Manuel, Röhrl Stefan, Maurer Carlo, Klenk Christian, Papargyriou Aristeidis, Schmidleitner Laura, Kabella Nicole, Shastri Akul, Fresacher David E, Harb Farid, Hafez Nawal, Bärthel Stefanie, Lucarelli Daniele, Escorial-Iriarte Carmen, Orben Felix, Öllinger Rupert, Emken Ellen, Fricke Lisa, Madej Joanna, Wustrow Patrick, Demir I Ekin, Friess Helmut, Lahmer Tobias, Schmid Roland M, Rad Roland, Schneider Günter, Kuster Bernhard, Saur Dieter, Hayden Oliver, Diepold Klaus, Reichert Maximilian
Abstract excerpt
Resistance to chemotherapy of pancreatic ductal adenocarcinoma (PDAC) is largely driven by intratumoral heterogeneity (ITH) due to tumor cell plasticity and clonal diversity. To develop alternative strategies to overcome this defined mechanism of resistance, tools to monitor and quantify ITH in a rapid and scalable fashion are needed urgently. Here, we employed label-free digital holographic microscopy (DHM) to...
Read the complete abstract on PubMedTopics
- Pancreatic Neoplasms
- Single-Cell Analysis
- Humans
